GL1X · GenesisL1 explorer

MolNFT v1 · #174194 · protein

Crystal structure of the SARS-cov-2 receptor binding domain in complex with antibody ion-300

7BNV · Surface glycoprotein: “Crystal structure of the SARS-cov-2 receptor binding domain in complex with antibody ion-300”. X-ray diffraction, 1 ligand (NAG), 6 pockets (best druggability 0.61). MolNFT v1 #174194 on GenesisL1: 3D…

PDB
7BNV
Type
protein
Length
633 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Surface glycoprotein; Heavy chain; Light chain
UniProt
A0A6M5UN06
Ligands
NAG
Pockets
6 · best druggability 0.61

Structure

x-ray diffraction · 3 distinct chains · 8% helix, 43% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASurface glycoproteinprotein19413% helix, 30% strandA0A6M5UN06
HHeavy chainprotein2237% helix, 49% strand—
LLight chainprotein2166% helix, 49% strand—

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13520.610.7852empty
22140.580.8027empty
33290.530.7446empty
41210.400.7528empty
5650.320.7516empty

Interfaces

3 interfaces between chains.

  • H–L · 1819 Ų buried · 11 hydrogen bonds · protein-protein
  • A–H · 710 Ų buried · 8 hydrogen bonds · protein-protein
  • A–L · 57 Ų buried · 0 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 8 disulfide, 1 glycan (disulfide, N-glycosylation).

Compared structures

  • 7BNV · Crystal Structure of the SARS-CoV-2 Receptor Binding Domain in Complex with Antibody… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.